CBS 2019
CBSMD教育中心
English

推荐文献

科研文章

荐读文献

Management of Percutaneous Coronary Intervention Complications: Algorithms From the 2018 and 2019 Seattle Percutaneous Coronary Intervention Complications Conference The Prognostic Value of Exercise Echocardiography After Percutaneous Coronary Intervention Impact of percutaneous coronary intervention extent, complexity and platelet reactivity on outcomes after drug-eluting stent implantation Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie? Hs-cTroponins for the prediction of recurrent cardiovascular events in patients with established CHD - A comparative analysis from the KAROLA study Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association’s COVID-19 Cardiovascular Disease Registry Systematic Review for the 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines Older Adults in the Cardiac Intensive Care Unit: Factoring Geriatric Syndromes in the Management, Prognosis, and Process of Care: A Scientific Statement From the American Heart Association Best Practices for the Prevention of Radial Artery Occlusion After Transradial Diagnostic Angiography and Intervention An International Consensus Paper Large-Bore Radial Access for Complex PCI: A Flash of COLOR With Some Shades of Grey

Guideline2018 Sep 24;46(9):680-694.

JOURNAL:中华心血管病杂志 Article Link

稳定性冠心病诊断与治疗指南

中华医学会心血管病学分会介入心脏病学组, 中华医学会心血管病学分会动脉粥样硬化与冠心病学组, 中国医师协会心血管内科医师分会血栓防治专业委员会, 等. Keywords: Angina pectoris; Coronary revascularization; Guidelines; Myocardial ischaemia; Risk factors; Stable coronary artery disease; anti-ischaemic drugs

摘要

2007年由中华医学会心血管病学分会多位专家组成的联合委员会制订的"慢性稳定性心绞痛诊断与治疗指南",充分采用中国人群流行病学和临床研究证据、结合国外研究结果及指南建议,对我国稳定性冠心病(stable coronary artery disease,SCAD)的防治工作起到了重要的指导作用。近10年来,由于循证医学证据的持续更新,对于SCAD病理生理机制的认识、疾病的诊断方法及治疗手段有了更加深入的理解。为此,中华医学会心血管病学分会介入心脏病学组、动脉粥样硬化与冠心病学组、中国医师协会心血管内科医师分会血栓防治专业委员会及中华心血管病杂志编辑委员会组织专家组,在近年发布的新技术和新药物临床应用循证证据的基础上,参考国内外指南,结合我国实际情况,对2007版指南进行了内容更新,为我国SCAD患者的诊治提供依据和原则,帮助临床医生做出医疗决策。